Skip to main content

Month: June 2022

Vaxart Reports Positive Preliminary Data from the Phase 1b Trial of its Oral Norovirus Vaccine Candidates in Elderly Adults

Results support safety and immunogenicity of the vaccine candidate in the highly vulnerable elderly population Preliminary boost study data also reported Norovirus has been estimated to cost the United States $10.6 billion annually SOUTH SAN FRANCISCO, Calif., June 02, 2022 (GLOBE NEWSWIRE) — Vaxart (NASDAQ: VXRT) today reported positive preliminary data from its recently completed Phase 1b trial of its oral vaccine candidate in subjects aged 55 – 80 years (NCT04854746). Results of the trial show a robust immune response across all doses, with a dose-dependent production of IgA antibody secreting cells (ASCs), consistent with previous studies conducted in younger populations. The results also demonstrate that the vaccine candidate was well tolerated with a favorable safety profile. These data support the continued development...

Continue reading

CleanTech Acquisition Corp. and Nauticus Robotics Announce Upcoming Conference Participation

NEW YORK and HOUSTON, June 02, 2022 (GLOBE NEWSWIRE) — CleanTech Acquisition Corp. (“CLAQ”) (NASDAQ: CLAQ), a publicly traded special purpose acquisition company, and Nauticus Robotics, Inc. (“Nauticus”), a Houston-area developer of offshore subsea and surface robots and autonomy software, will be presenting at Cowen’s 2nd Annual Sustainability & Energy Transition Summit and Roth’s 8th Annual London Conference. Cowen’s 2nd Annual Sustainability & Energy Transition SummitCowen’s 2nd Annual Sustainability & Energy Transition Summit is being held virtually on June 7-8, 2022. Participating from the companies are Eli Spiro, Chief Executive Officer of CLAQ, and Nicolaus Radford, Chairman and Chief Executive Officer of Nauticus. Management will be hosting one-on-one meetings with investors. Roth’s 8th Annual London ConferenceRoth’s...

Continue reading

E-Home Household Services Holdings Limited Awarded RMB18 million Property Cleaning Contracts During April-May

FUZHOU, China, June 02, 2022 (GLOBE NEWSWIRE) — E-Home Household Service Holdings Limited (Nasdaq: EJH) (the “Company” or “E-Home”), a provider of integrated household services in China, today announced the Company has been awarded RMB18 million new contracts during April-May to provide property cleaning services for neighborhood residences. The Company signed RMB5 million of the service contracts and Putian YouYou Cleaning Co., Ltd. (“YouYou”), a subsidiary of the Company, was awarded RMB13 million of the new business. YouYou is a leading cleaning services provider and a member enterprise at Fujian Province Cleaning Industry Association and E-Home acquired 60% of equity interests in YouYou in January. Under the contract, the Company and YouYou will provide concentrated sweep through designated neighborhoods...

Continue reading

InterCure and Cookies Successfully Launch Flagship Pharmacy in Be’er Sheva, Israel

Cookies Be’er Sheva is the largest medical cannabis dedicated pharmacy in IsraelCookies Pharmacy in Be’er Sheva Cookies Pharmacy in Be’er ShevaNEW YORK and TORONTO and HERZLIYA, Israel, June 02, 2022 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (“InterCure” or the “Company”) announced today the grand opening of its flagship Cookies pharmacy in Be’er Sheva, the largest city in Israel’s southern region, known as the capital of the Negev. The pharmacy is located in the center of Be’er Sheva in front of City Hall, in a unique building that covers an area of ​​over 1,000 square meters and is painted entirely in the globally recognized Cookies baby blue. To the Company’s knowledge, this is the largest medical cannabis dedicated pharmacy in the world. The...

Continue reading

mPhase Announces Initial EV Charging Locations in Florida, Enters Supermarket Site Market

Rockville, MD, June 02, 2022 (GLOBE NEWSWIRE) — mPhase Technologies, Inc. (OTC Pink: XDSL) (“mPhase” or the “Company”), a technology company developing the mPower EV+ (electric vehicle) charging network and consumer engagement platform, today announced the completion of site selection for the first five mPower EV charging locations in the State of Florida, consisting of two gas stations, two supermarkets, and one deli property. These initial locations are in Fort Myers, Orlando, Palm Bay, Palm Coast, and Scottsmoor. The sites are expected to have an average of four level 2 chargers branded under the mPower name. Strategic selection across the mPower network is concentrated on sites with proximity to high traffic roadways, affiliation with major regional and national brands, and onsite amenities such as restaurants, car washes and...

Continue reading

Solid Biosciences Reports Inducement Grant to New Senior Vice President, Quality

CAMBRIDGE, Mass., June 02, 2022 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the grant of inducement awards to its newly appointed Senior Vice President, Quality, Mark Tucker, PhD. The grant was approved by a majority of the independent directors of the Company on April 25, 2022 as an inducement material to Dr. Tucker entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement grant to Dr. Tucker consisted of an option to purchase up to 120,000 shares of common stock and a restricted stock unit award with respect to 60,000 shares of common stock. The option has a ten-year term and an exercise price of $0.57 per share, the closing price per share...

Continue reading

SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields Another Patent Application for their Proprietary Psychedelic Combination to Treat Cocaine Addiction

No dedicated treatment currently available for cocaine addiction TEL AVIV, Israel, June 02, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today announced that its recently launched collaboration with Clearmind Medicine Inc. (“Clearmind”) (CSE: CMND), (OTC: CMNDF), (FSE: CWY0), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, resulted in the filing of a provisional patent application related to treating cocaine addiction. The patent application refers to the proprietary combination of SciSparc’s CannAmide™ with Clearmind’s MEAI,...

Continue reading

Procaps Group Reports Preliminary First Quarter 2022 Results

Net Revenues Increased by 11% to U$ 86 million, with Adjusted EBITDA Up 15% Year-Over-Year to $9 Million MIAMI and BARRANQUILLA, Colombia, June 02, 2022 (GLOBE NEWSWIRE) — Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its preliminary financial results for the quarter ended March 31, 2022 (“Q1-22”). Preliminary Q1-22 Results HighlightsNet revenues for Q1-22 totaled $86 million, an increase of 11% when compared with the quarter ended March 31, 2021 (“Q1-21”), primarily driven by strong demand across Procaps Colombia, CAN and CASAND, as well as from our continued rollout of new product launches. Adjusted EBITDA increased by 15% to $9 million for Q1-22, with an Adjusted EBITDA margin of 11% for the quarter.   Q122 Q121 Δ%Net Revenues 86...

Continue reading

Cerberus Sentinel completes acquisition of Creatrix, Inc.

U.S. cybersecurity services firm expands security and identity management services with woman-owned business Scottsdale, Ariz., June 02, 2022 (GLOBE NEWSWIRE) — via Investor Wire — Cerberus Cyber Sentinel Corporation (NASDAQ: CISO), a cybersecurity consulting and managed services firm based in Scottsdale, Ariz., announced that it has completed the acquisition of Creatrix, Inc., a woman-owned cybersecurity and information technology company based in Tennessee and Maryland. Under the terms of the agreement, Creatrix will become a wholly owned subsidiary of Cerberus Sentinel. The company was co-founded by Anna Fleeman, founder and managing director, and Sami Elhini, co-founder and president. Creatrix is recognized for its expertise in identity management as well as systems integration and software engineering, and it specializes...

Continue reading

Arbutus to Participate in June Investor Conferences

WARMINSTER, Pa., June 02, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Company will participate in the following upcoming investor conferences taking place in New York: Jefferies Healthcare Conference (June 8 – 10, 2022)Fireside Chat: 3:00 pm ET on Thursday, June 9, 2022 Presenters: Michael McElhaugh, Chief Business Officer; Dr. Gaston Picchio, Chief Development Officer; and David Hastings, Chief Financial OfficerJMP Securities Life Sciences Conference (June 15 – 16, 2022)Fireside Chat: 9:00 am ET on Wednesday, June 15, 2022 Presenters: Michael McElhaugh, Chief Business Officer; Dr. Michael Sofia; Dr. Gaston Picchio,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.